TTrialPathMatch Me to Trials
← Back to study

Eligibility check

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Step 1 of 5

Where are you located?

We confirm your state so we only show studies you can actually reach.

Your answers help match you to studies and connect you with the research team. They're handled per our Privacy Policy.